Abstract
The primary mechanism of activation of intracellular prohormones seems to involve proteolytic cleavage at sequences of consecutive basic residues1. Thus, all the known biologically active peptides derived from the prohormone of corticotropin and β-endorphin appear to be excised initially by enzymes with this specificity. The C-terminal peptide, β-endorphin (1–31), is generated by cleavage at a lysyl arginine sequence and an additional cleavage can give rise to the related peptides, β-endorphin (1–27) and β-endorphin (1–26). These derivatives of β-endorphin are released by an endopeptidase that appears to catalyse cleavage on the carboxyl side of paired lysine residues, followed by the action of a carboxypeptidase B-like enzyme (Fig. 1). The β-endorphin fragments, β-endorphin (1–27) and β-endorphin (1–26), have been isolated from porcine2–4 and bovine pituitary5 but the C-terminal dipeptide, glycyl glutamine, has not been reported previously. Here we describe the isolation of glycyl glutamine from porcine pituitary and present evidence for its presence in sheep brain stem. When applied ionophoretically to brain stem neurones in the rat, the dipeptide exhibited an inhibitory action on cell firing.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Steiner, D. F., Quinn, P. S., Chan, S. J., Marsh, J. & Tager, H. S. Ann. N. Y. Acad. Sci. 343, 1–16 (1980).
Bradbury, A. F., Smyth, D. G. & Snell, C. R. Ciba Fdn Symp. 41, (new ser.) 61–74 (1976).
Smyth, D. G., Snell, C. R. & Massey, D. E. Biochem. J. 175, 261–270 (1978).
Smyth, D. G., Smith, C. C. & Zakarian, S. in Advances in Endogenous and Exogenous Opioids (ed. Takagi, H.) 145–148 (Kodansha/Elsevier, Tokyo–Amsterdam, 1981).
Massey, D. E. & Smyth, D. G. Biochem. Soc. Trans. 8, 751–752 (1980).
Smyth, D. G. & Zakarian, S. Nature 288, 613–615 (1980).
Smyth, D. G., Zakarian, S., Deakin, J. F. W. & Massey, D. E. Ciba Fdn Symp. 81, 79–96 (1981).
Jacobs, L. S., McKeel, D. W., Jarett, I. & Daughaday, W. H. Endocrinology 92, 477–486 (1973).
Smyth, D. G., Massey, D. E., Zakarian, S. & Finnie, M. D. A. Nature 279, 252–254 (1979).
Harris, J. J. & Lerner, A. B. Nature 179, 1346–1347 (1957).
Carter, S. J., Shuster, S. & Morley, J. Nature 279, 74–75 (1979).
Zakarian, S. & Smyth, D. G. Nature 296, 250–252 (1982).
Normanton, J. R., West, D. C. & Wolstencroft, J. R. Br. J. Pharmac. 77, 477–485 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Parish, D., Smyth, D., Normanton, J. et al. Glycyl glutamine, an inhibitory neuropeptide derived from β-endorphin. Nature 306, 267–270 (1983). https://doi.org/10.1038/306267a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/306267a0
This article is cited by
-
Glycyl-glutamine (β-endorphin30-31) inhibits morphine-induced dopamine efflux in the nucleus accumbens
Naunyn-Schmiedeberg's Archives of Pharmacology (2010)
-
Glycyl-l-Glutamine Disposition in Rat Choroid Plexus Epithelial Cells in Primary Culture: Role of PEPT2
Pharmaceutical Research (2005)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.